KURA Q3 2023 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$216,000

Operating Income

-$42M

Net Income

-$39M

EPS (Diluted)

$-0.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$474M

Total Liabilities

$44M

Stockholders' Equity

$430M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$216,000	$0	—
Operating Income	-$42M	-$37M	-16.1%
Net Income	-$39M	-$36M	-8.7%